期刊文献+

白细胞介素-28B rs12979860 T/C基因多态性与肝细胞癌易感性关系的Meta分析

Association between polymorphism of interleukin-28B rs12979860 T/C and susceptibility of hepatocellular carcinoma: a Meta-analysis
原文传递
导出
摘要 目的:探讨白细胞介素-28B(IL-28B)rs12979860 T/ C 基因多态性与肝细胞癌(HCC)易感性的关联。方法计算机检索 PubMed、EMBase、中国知网数据库、中国生物医学文献数据库、维普数据库及万方数据库,检索时间截至2014年9月30日,收集有关 IL-28B rs12979860 T/ C 基因多态性与肝细胞癌易感性的病例-对照研究。由2名研究者按照纳入和排除标准独立选择文献、提取资料,采用 Rev-Man 5.2和 Stata 12.0软件进行 Meta 分析。结果最终纳入6个病例-对照研究,包括1138例患者和955例对照。各遗传模型 Meta 分析结果显示,IL-28B rs12979860 T/ C 多态性与肝细胞癌易感性的关联性有统计学意义,与基因型 CC 及 CT + CC 比较,基因型 TT 可增加人群罹患肝细胞癌的风险(TT : CC:OR =2.26,95% CI 为1.40~3.64,Z =3.33,P =0.0009;TT : CT + CC:OR =1.90,95% CI 为1.23~2.93, Z =2.89,P =0.004)。种族来源的亚组分析结果显示,在白种人群中,IL-28B rs12979860 T/ C 多态性与肝细胞癌易感性存在显著相关性(TT : CC:OR =2.06,95% CI 为1.22~3.47,Z =2.70,P =0.007;TT :CT + CC:OR =1.71,95% CI 为1.07~2.72,Z =2.23,P =0.03)。结论 IL-28B rs12979860 T/ C 基因多态性与肝细胞癌易感性相关,基因型 TT 可增加罹患肝细胞癌的风险。 Objective To explore the correlation between polymorphism of interleukin-28B(IL-28B) rs12979860 T/ C and susceptibility of hepatocellular carcinoma( HCC). Methods All eligible case-control studies published up to 2014-09-30 were identified by searching PubMed,EMBase,CNKI,CBM,VIP and WanFang databases. Two reviews independently identified the literature according to inclusion and exclusion criteria. Meta-analysis was performed using Rev Man 5. 2 and Stata 12. 0 software. Results A total of 6 stud-ies comprising 1 138 cases and 955 controls were finally included. Meta-analysis showed that IL-28B rs12979860 T/ C polymorphism was associated with the susceptibility of HCC. Compared with the genotype CC and CT + CC,genotype TT increased the risk of suffering from HCC(TT vs CC:OR = 2. 26,95% CI:1. 40-3. 64,Z = 3. 33,P = 0. 000 9;TT vs CT + CC:OR = 1. 90,95% CI:1. 23-2. 93,Z = 2. 89,P = 0. 004). In stratification analysis by ethnicity,we observed that the polymorphism of IL-28B rs12979860 T/ C was associat-ed with the susceptibility of HCC among Caucasian populations(TT vs CC:OR = 2. 06,95% CI:1. 22-3. 47, Z = 2. 70,P = 0. 007;TT vs CT + CC:OR = 1. 71,95% CI:1. 07-2. 72,Z = 2. 23,P = 0. 03). Conclusion The polymorphism of IL-28B rs12979860 T/ C is associated with the susceptibility of HCC,genotype TT may increase the susceptibility to HCC.
出处 《国际肿瘤学杂志》 CAS 2015年第5期342-346,共5页 Journal of International Oncology
关键词 肝肿瘤 多态现象 遗传 META分析 白细胞介素28B Liver neoplasms Polymorphism, genetic Meta-analysis Interleukin 28B
  • 相关文献

参考文献1

二级参考文献12

  • 1Javier García-Samaniego,Miriam Romero,Rafael Granados,Remedios Alemán,Miguel Jorge Juan,Dolores Suárez,Ramón Pérez,Gregorio Castellano,Carlos González-Portela.Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C[J].World Journal of Gastroenterology,2013,19(12):1943-1952. 被引量:2
  • 2A.Fraser,A.Austin,G. R.Foster,P. C.Hayes,P. R.Mills,S. D.Ryder.UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients[J]. Aliment Pharmacol Ther . 2012 (6)
  • 3AntonioCraxì.2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines[J]. Liver Int . 2011
  • 4Chun-Tao Wai,Joel K. Greenson,Robert J. Fontana,John D. Kalbfleisch,Jorge A. Marrero,Hari S. Conjeevaram,Anna S.-F. Lok.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J].Hepatology.2003(2)
  • 5Ivana Lazarevic,Jelena Djordjevic,Maja Cupic,Danijela Karalic,Dragan Delic,Neda Svirtlih,Jasmina Simonovic,Petar Svorcan,Natasa Milic,Tanja Jovanovic.The influence of single and combined IL28B polymorphisms on response to treatment of chronic hepatitis C[J].Journal of Clinical Virology.2013
  • 6Andri Rauch,Zoltán Kutalik,Patrick Descombes,Tao Cai,Julia Di Iulio,Tobias Mueller,Murielle Bochud,Manuel Battegay,Enos Bernasconi,Jan Borovicka,Sara Colombo,Andreas Cerny,Jean–Fran?ois Dufour,Hansjakob Furrer,Huldrych F. Günthard,Markus Heim,Bernard Hirschel,Raffaele Malinverni,Darius Moradpour,Beat Müllhaupt,Andrea Witteck,Jacques S. Beckmann,Thomas Berg,Sven Bergmann,Francesco Negro,Amalio Telenti,Pierre–Yves Bochud.Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study[J].Gastroenterology.2010(4)
  • 7Kentaro Matsuura,Tsunamasa Watanabe,Yasuhito Tanaka.Role of IL28B for chronic hepatitis C treatment toward personalized medicine[J].J Gastroenterol Hepatol.2014(2)
  • 8B. Maasoumy,K. Port,B. Calle Serrano,A. A. Markova,L. Sollik,M. P. Manns,M. Cornberg,H. Wedemeyer.The clinical significance of drug–drug interactions in the era of direct‐acting anti‐viral agents against chronic hepatitis C[J].Aliment Pharmacol Ther (-).2013(11-12)
  • 9John M. Vierling,Mitchell Davis,Steven Flamm,Stuart C. Gordon,Eric Lawitz,Eric M. Yoshida,Joseph Galati,Velimir Luketic,Jonathan McCone,Ira Jacobson,Patrick Marcellin,Andrew J. Muir,Fred Poordad,Lisa D. Pedicone,Janice Albrecht,Clifford Brass,Anita Y.M. Howe,Lynn Y. Colvard,Frans A. Helmond,Weiping Deng,Michelle Treitel,Janice Wahl,Jean-Pierre Bronowicki.Boceprevir for Chronic HCV Genotype 1 Infection in Patients with Prior Treatment Failure to Peginterferon/Ribavirin, including Prior Null Response[J].Journal of Hepatology.2013
  • 10Christoph Sarrazin,Christophe Hézode,Stefan Zeuzem,Jean-Michel Pawlotsky.Antiviral strategies in hepatitis C virus infection[J].Journal of Hepatology.2012

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部